The pharmaceutical industry relies on a diverse array of chemical intermediates to develop life-saving drugs and advanced medical technologies. Among these, Glycolide (CAS 502-97-6) holds a significant position, primarily as a monomer for synthesizing biodegradable polymers that are revolutionizing healthcare. As a key pharmaceutical intermediate, its quality and availability are critical.
Glycolide is the cyclic dimer of glycolic acid, and its ability to undergo ring-opening polymerization makes it an ideal precursor for Polyglycolic Acid (PGA) and its copolymers, such as PLGA. These polymers are not just biodegradable but also biocompatible, meaning they can be safely used within the human body without eliciting adverse reactions. This dual characteristic is what makes them indispensable in modern medicine.
One of the most impactful applications of Glycolide-derived polymers is in the creation of resorbable medical devices. Surgical sutures made from PGA degrade naturally over time, eliminating the need for removal and reducing patient discomfort. Similarly, bone fixation devices, such as screws and plates, fabricated from these biodegradable materials provide temporary support during healing and are gradually absorbed by the body, facilitating a more natural recovery process. When you buy Glycolide CAS 502-97-6 for pharmaceutical applications, ensuring high purity is non-negotiable.
Furthermore, Glycolide is instrumental in the development of sophisticated drug delivery systems. Polymer matrices formed from Glycolide can encapsulate active pharmaceutical ingredients (APIs) and release them in a controlled, sustained manner over days, weeks, or even months. This targeted release mechanism enhances therapeutic efficacy, minimizes dosing frequency, and improves patient compliance. The precise control over degradation and release kinetics makes Glycolide an invaluable intermediate for pharmaceutical innovation.
The synthesis of these advanced polymers requires a monomer of exceptional purity. As a dedicated pharmaceutical intermediate supplier, we understand the stringent requirements of the medical and pharmaceutical sectors. Our Glycolide (CAS 502-97-6) is manufactured under rigorous quality control standards to ensure it meets the demands for producing safe and effective medical devices and drug delivery systems. Partnering with a reliable PGA monomer manufacturer ensures you receive consistent quality for your critical applications.
The continuous research and development in biomaterials underscore the growing importance of Glycolide. As the pharmaceutical industry seeks novel solutions for patient care, the demand for high-quality intermediates like Glycolide will only increase. We are committed to supporting these advancements by providing reliable access to this essential compound. If you are seeking Glycolide for your pharmaceutical or medical device applications, contact us for a quote and to learn more about our product offerings. Let us be your trusted partner in advancing healthcare through innovative materials.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.